Compass Therapeutics (CMPX) Total Liabilities (2018 - 2026)
Compass Therapeutics (CMPX) posted Total Liabilities of $18.7 million for Q1 2026, down 17.98% sequentially from $22.8 million in Q4 2025, and down 11.69% YoY from $21.2 million in Q1 2025.
Compass Therapeutics (CMPX) Total Liabilities (2018 - 2026) Analysis & Trends
Compass Therapeutics has reported Total Liabilities for 9 years, with the latest figure at $18.7 million in Q1 2026.
- Quarterly Total Liabilities fell 11.69% year-over-year to $18.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.7 million (down 11.69% YoY) and the FY2025 annual result came in at $22.8 million, up 50.28% from the prior year.
- Total Liabilities declined to $18.7 million in Q1 2026 per CMPX's latest filing, from $22.8 million in the prior quarter.
- Over five years, Total Liabilities peaked at $23.5 million in Q2 2025 and troughed at $4.1 million in Q1 2024.
- A 5-year average of $14.4 million and a median of $12.7 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities plunged 67.88% in 2024, then soared 418.67% in 2025.
- Over 5 years, Total Liabilities stood at $18.0 million in 2022, then sank by 53.7% to $8.3 million in 2023, then jumped by 81.96% to $15.2 million in 2024, then soared by 50.28% to $22.8 million in 2025, then declined by 17.98% to $18.7 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $18.7 million, $22.8 million, and $21.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | 24.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.12 Mn |
| Mar 31, 2026 | 18.70 Mn |
| Dec 31, 2025 | 22.80 Mn |
| Sep 30, 2025 | 21.65 Mn |
| Jun 30, 2025 | 23.49 Mn |
| Mar 31, 2025 | 21.17 Mn |
| Dec 31, 2024 | 15.17 Mn |
| Sep 30, 2024 | 10.75 Mn |
| Jun 30, 2024 | 9.51 Mn |
| Mar 31, 2024 | 4.08 Mn |
| Dec 31, 2023 | 8.34 Mn |
| Sep 30, 2023 | 9.99 Mn |
| Jun 30, 2023 | 10.90 Mn |
| Mar 31, 2023 | 12.71 Mn |
| Dec 31, 2022 | 18.01 Mn |
| Sep 30, 2022 | 11.72 Mn |
| Jun 30, 2022 | 13.33 Mn |
| Mar 31, 2022 | 12.07 Mn |
| Dec 31, 2021 | 13.68 Mn |
| Sep 30, 2021 | 11.01 Mn |